Metastatic Colorectal Cancer First-Line Treatment With Bevacizumab: The Impact of K-Ras Mutation
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s43828
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
Informa UK Limited